Ralph A DeFronzo, MD
University of Texas · The University of Texas Health Science Center at San Antonio · The University of Texas Health Science at San Antonio
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ralph A DeFronzo, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:41 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05838287 · Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus ParticipantsThe University of Texas Health Science Center at San Antonio · recruiting · Type 2 Diabetes Mellitus in Obese, Heart Failure With Preserved Ejection Fraction · principal investigator
- Ph1NCT03560323 · Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1The University of Texas Health Science Center at San Antonio · completed · Heart Failure, Type 2 Diabetes Mellitus · principal investigator
- Ph4NCT03168295 · PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to GlucosuriaThe University of Texas Health Science Center at San Antonio · completed · Diabetes Mellitus, Type 2 · principal investigator
- N/ANCT02969798 · Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)The University of Texas Health Science Center at San Antonio · recruiting · Diabetes Mellitus, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG) · principal investigator
- N/ANCT02613897 · ESR-15-11293 - Saxa/Dapa, Safety and Efficacy StudyThe University of Texas Health Science Center at San Antonio · completed · Diabetes Mellitus, Type 2 · study director
- Ph3NCT02592421 · SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2The University of Texas Health Science Center at San Antonio · completed · Type II Diabetes Mellitus · principal investigator
- Ph2NCT02535715 · A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)The University of Texas Health Science Center at San Antonio · completed · Type 1 Diabetes · principal investigator
- Ph4NCT02299050 · Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue TherapyThe University of Texas Health Science Center at San Antonio · completed · Type 2 Diabetes · principal investigator
- Ph2NCT01972152 · Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe HypoglycemiaXeris Pharmaceuticals · completed · Hypoglycemia · principal investigator
- Ph4NCT01588470 · Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)The University of Texas Health Science Center at San Antonio · completed · Type 2 Diabetes, Coronary Heart Disease · principal investigator
- Ph3NCT00230464 · Acute Metabolic Effects of LAF 237 in Type 2 DiabeticsThe University of Texas Health Science Center at San Antonio · completed · Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 44 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Ketones, Muscle Metabolism, and SGLT2 InhibitorsR01DK107680 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI RALPH A DEFRONZO · fiscal years 2016 to 2026
- SGLT2 Inhibitors, Ketogenesis, and KetoacidosisR01DK024092 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI RALPH A DEFRONZO · fiscal years 1986 to 2026Named on NCT02969798
- Improved Hypoglycemia Rescue DeviceR44DK085809 · NIDDK · XERIS PHARMACEUTICALS, INC. · PI RALPH A DEFRONZO, JOHN KINZELL · fiscal years 2011 to 2012Named on NCT01972152
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:41 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed